-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LTsuBRHnNmm1nA7YxNOREX8ct7kJnezuQ2QoTl3AOjCxSl9CODokKzCKwKl2lxsb
 0CrKB2JdVap4h6u5zLFf5Q==

<SEC-DOCUMENT>9999999997-05-042117.txt : 20051013
<SEC-HEADER>9999999997-05-042117.hdr.sgml : 20051013
<ACCEPTANCE-DATETIME>20051013142050
<PAPER>
ACCESSION NUMBER:		9999999997-05-042117
CONFORMED SUBMISSION TYPE:	REGDEX
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		
FILED AS OF DATE:		20051011
DATE AS OF CHANGE:		20051013
EFFECTIVENESS DATE:		20051011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neogenix Oncology Inc
		CENTRAL INDEX KEY:			0001341293
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		REGDEX
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	021-82031
		FILM NUMBER:		05068473

	BUSINESS ADDRESS:	
		STREET 1:		445 NORTHERN BLVD STE 24
		CITY:			GREAT NECK
		STATE:			NY
		ZIP:			11021

	MAIL ADDRESS:	
		STREET 1:		445 NORTHERN BLVD STE 24
		CITY:			GREAT NECK
		STATE:			NY
		ZIP:			11021
</SEC-HEADER>
<DOCUMENT>
<TYPE>REGDEX
<SEQUENCE>1
<FILENAME>9999999997-05-042117.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 05068473 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----